Canada markets closed

GenSight Biologics S.A. (GSGTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.45000.0000 (0.00%)
At close: 12:14PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,267
1,267
2,582
5,276
4,394
Operating Expenses
Research Development
19,360
19,360
19,343
22,554
21,989
Selling General and Administrative
7,267
7,267
8,237
5,894
3,484
Total Operating Expenses
30,963
30,963
30,417
33,401
29,329
Operating Income or Loss
-29,696
-29,696
-27,835
-28,125
-24,935
Interest Expense
3,152
3,152
2,650
2,166
1,717
Income Before Tax
-26,221
-26,221
-27,619
-28,615
-34,015
Income Tax Expense
0
0
5
2
2
Income from Continuing Operations
-26,221
-26,221
-27,624
-28,617
-34,017
Net Income
-26,220
-26,220
-27,625
-28,617
-34,015
Net Income available to common shareholders
-26,220
-26,220
-27,625
-28,617
-34,015
Basic EPS
-0.63
-
-0.60
-0.63
-0.97
Diluted EPS
-0.63
-
-0.60
-0.63
-0.97
Basic Average Shares
46,205
-
46,330
45,151
35,127
Diluted Average Shares
46,205
-
46,330
45,151
35,127